Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avidity Biosciences, Inc. - Common Stock
(NQ:
RNA
)
71.87
-0.10 (-0.14%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avidity Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Which stocks are gapping on Monday?
↗
October 27, 2025
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Janus Henderson, Avidity Biosciences, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday
↗
October 27, 2025
Via
Benzinga
These stocks are moving in today's pre-market session
↗
October 27, 2025
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Dow Futures Rise As China Trade Tensions Ease: NVDA, MP, BA, RNA Among Stocks To Watch
↗
October 27, 2025
Via
Stocktwits
Topics
Stocks
World Trade
Why Is Avidity Biosciences Stock Down 20% Pre-market Today?
↗
September 11, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 27, 2025
Via
Benzinga
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday
↗
October 27, 2025
Via
Benzinga
This Harley-Davidson Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
↗
October 27, 2025
Via
Benzinga
Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal
↗
October 27, 2025
Avidity Biosciences (NASDAQ: RNA) shares soar as Novartis (NYSE: NVS) agrees to acquire them for $12 billion in cash.
Via
Benzinga
Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today
↗
October 27, 2025
Novartis has agreed to buy Avidity Biosciences in a deal valued at $72 per share.
Via
Stocktwits
Stock Market Today: Dow Jones, S&P 500 Futures Climb Ahead Of Busy Week On Wall Street—Novartis, Nucor, Waste Management In Focus
↗
October 27, 2025
U.S. stock futures rose on Monday following Friday’s positive moves. Futures of major benchmark indices were higher.
Via
Benzinga
Topics
Stocks
Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
↗
October 27, 2025
Via
Benzinga
RNA STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF AVIDITY BIOSCIENCES, INC. IS FAIR TO SHAREHOLDERS
October 26, 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
From
Halper Sadeh LLC
Via
GlobeNewswire
Is Avidity Biosciences Inc Gaining or Losing Market Support?
↗
October 22, 2025
Via
Benzinga
Looking Into Avidity Biosciences's Recent Short Interest
↗
September 23, 2025
Via
Benzinga
Crude Oil Rises 1%; Manufacturing Activity in New York Falls In September
↗
September 15, 2025
Via
Benzinga
IBEX, Tesla, IonQ, Warner Bros. Discovery And Other Big Stocks Moving Higher On Friday
↗
September 12, 2025
Via
Benzinga
Nasdaq Jumps Over 150 Points; Kroger Earnings Top Estimates
↗
September 11, 2025
Via
Benzinga
Thursday's session: gap up and gap down stocks
↗
September 11, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Why Oxford Industries Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
↗
September 11, 2025
Via
Benzinga
Discover the top movers in Thursday's pre-market session.
↗
September 11, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
September 11, 2025
Via
Benzinga
Lovesac, Avidity Biosciences, Veritone And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
September 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 10, 2025
Via
Benzinga
Wednesday's after hours session: top gainers and losers
↗
September 10, 2025
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Avidity Drug Shows Yearlong Gains In Duchenne Muscular Dystrophy Trial
↗
September 10, 2025
Avidity's del-zota treatment improved muscle function, increased dystrophin levels, and reduced damage markers in Duchenne muscular dystrophy after one year.
Via
Benzinga
Deep Dive Into Avidity Biosciences Stock: Analyst Perspectives (8 Ratings)
↗
September 10, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
September 09, 2025
Via
Benzinga
Avidity Biosciences (NASDAQ:RNA) Exhibits High-Quality Technical Breakout Setup
↗
September 05, 2025
Avidity Biosciences (RNA) stock shows a strong technical breakout setup with high momentum, trading above key moving averages in a bullish trend.
Via
Chartmill
Avidity (RNA) Q2 Revenue Jumps 88%
↗
August 07, 2025
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.